5432132026-06-275432132026-06-272026-06-27RelatedPartyTransactionDomain15432132026-06-272026-06-27ResolutionOrAgendaDomain15432132026-06-27ResolutionOrAgendaDomain15432132026-06-272026-06-27ResolutionOrAgendaDomain25432132026-06-27ResolutionOrAgendaDomain25432132026-06-272026-06-27ResolutionOrAgendaDomain35432132026-06-27ResolutionOrAgendaDomain35432132026-06-272026-06-27ResolutionOrAgendaDomain45432132026-06-27ResolutionOrAgendaDomain45432132026-06-272026-06-27ResolutionOrAgendaDomain55432132026-06-27ResolutionOrAgendaDomain55432132026-06-272026-06-27ResolutionOrAgendaDomain65432132026-06-27ResolutionOrAgendaDomain65432132026-06-272026-06-27ResolutionOrAgendaDomain75432132026-06-27ResolutionOrAgendaDomain75432132026-06-272026-06-27ResolutionOrAgendaDomain85432132026-06-27ResolutionOrAgendaDomain8iso4217:INRxbrli:pureRossari Biotech LimitedROSSARINew2026-06-2623:00:002026-06-27Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)17Monday2026-07-2011:00:00Mumbai8Rossari Biotech LimitedUnitop Chemicals Private LimitedSubsidiaryAny other transactionThe transactions involves: 1. Purchase of Goods including raw material, finished goods, semifinished goods and traded products. 2. Sale of goods including raw materials, finished goods, semifinished goods, and traded products. 3. Sale of Services including commission on sales and consultancy, business auxiliary, marketing and job working. 4. Infrastructure & Resource Sharing including recovery/ reimbursement of expenses. 5. Purchase and Sale of Plant & Equipment. 6. Any other transactions for business purpose from/to UCPL during Financial Year 2025-26102900000002026-04-012027-03-31Proposed tranactions are recurring in nature and approval is sought for the Financial Year 2026-27Ordinary ResolutionAdoption of Financial StatementsAdoption of the audited standalone financial statement of the Company for the Financial Year ended 31st March, 2026 and the reports of the Board of Directors and Auditors thereonOrdinary ResolutionAdoption of Financial StatementsAdoption of the audited consolidated financial statement of the Company for the Financial Year ended 31st March, 2026 and the report of Auditors thereonOrdinary ResolutionIssuance/Corporate ActionDividendDeclaration of dividend for the Financial Year ended 31st March, 2026Ordinary ResolutionOthersOthersAppointment of director liable to retire by rotationAppointment of Mr. Edward Menezes (DIN: 00149205) as a director liable to retire by rotationOrdinary ResolutionRelated Party TransactionMaterial Related Party Transaction(s) with Unitop Chemicals Private LimitedSpecial ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationAppointmentAppointment of Mr. Udeypaul Singh Gill (DIN: 00004340), as a Non-Executive, Independent Director of the CompanyNon-Executive - Independent DirectorMr. Udeypaul Singh Gill000043402026-04-282029-04-273Special ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRe-appointmentRe-appointment of Ms. Esha Padmanabhan Achan (DIN: 10350369), as a Non-Executive, Independent Director of the CompanyNon-Executive - Independent DirectorMs. Esha Padmanabhan Achan103503692026-10-212029-10-203Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRemunerationRatification of remuneration payable to M/s. R. Shetty & Associates, Cost Auditors of the CompanyOthersCost AuditorsM/s. R. Shetty & Associates2026-04-012027-03-31135000